How is information on adverse events shared?
In addition to monitoring the rates of adverse events across the country, the Government of Canada will be meeting regularly with provincial, territorial and international experts to review safety data as it become available from ongoing clinical trials around the world. A working group of vaccine safety experts will also be meeting to review any serious adverse event reports from international partners. This will help public health experts to identify trends and patterns in adverse events early on, and to actively seek out and investigate any similar reports within Canada.
